TRUST CO OF TOLEDO NA /OH/
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1008937
HOLLAND, OH
Position in REGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,364
-$1,817 QoQ
Shares Held
7
-12.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,262
of 1,322 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRUST CO OF TOLEDO NA /OH/ holds $2,575,716 across 12 Biotechnology names. REGN ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
124,002 | $2,312,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
244 | $121,201 | |
| 3 | LCTX |
Lineage Cell Therapeutics, Inc.
|
83,795 | $109,771 | |
| 4 | CRDF |
Cardiff Oncology, Inc.
|
9,000 | $11,700 | |
| 5 | ATYR |
aTYR PHARMA INC
|
16,640 | $9,934 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
7 | $4,364 | |
| 7 | CRMD |
CorMedix Inc.
|
360 | $2,826 | |
| 8 | EDIT |
Editas Medicine, Inc.
|
500 | $1,620 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,364 | 7 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $6,181 | 8 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,403 | 7 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,935 | 7 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $4,200 | 8 | Shares | Sole | 2025-07-24 | |
| No filing history on record for this holder in this stock. | ||||||